HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: Adequacy of the New Pediatric Isoniazid/Rifampin/Pyrazinamide (HRZ) Tablet
This clinical trial update reports on the adequacy of a new pediatric HRZ tablet (isoniazid/rifampin/pyrazinamide) for treating tuberculosis…
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: Trends of Morbidity and Mortality Among Thai HIV-infected and HIV-uninfected Patients: a Five-year Prospective Cohort Study
A five-year prospective cohort study assessing morbidity and mortality in Thai individuals with HIV infection compared with HIV-uninfected c…
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: Client and Provider Preferences for HIV Care
This completed study from the Thai Red Cross AIDS Research Centre examined client and provider preferences for HIV care and related interact…
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: Study to Evaluate the Feasibility of Integrating the Point-of-care Testing for Sexually Transmitted Infections and HIV Into Community-based Clinics for MSM and TGW in Thailand
Feasibility study update on integrating point-of-care testing for HIV and sexually transmitted infections into community-based clinics servi…
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: Assessment of Drug-drug Interactions Between Masculinizing Hormone Therapy and Antiretroviral Agents Concomitantly for Pre-exposure Prophylaxis Among Transgender Men [NA]
This clinical trial update investigates potential drug-drug interactions between masculinizing hormone therapy and antiretroviral agents use…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: Thai MSM/TG Test and Treat Study
This update reports the completion of a Thai trial evaluating HIV testing uptake and acceptance of immediate antiretroviral therapy.
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: Evaluation of PrEP-30: a Demonstration Project of Pre-exposure Prophylaxis for MSM and Other High-risk Group Clients at the Thai Red Cross Anonymous Clinic
This entry provides a clinical trial update on PrEP-30, a demonstration project for pre-exposure prophylaxis among MSM and other high-risk g…
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: UTECH: Machine Learning for HIV Prevention Among Substance Using GBMSM [NA]
The UCLA-led trial evaluating machine learning for HIV prevention among substance-using GBMSM has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: Study to Evaluate Safety, Tolerance and Efficacy of ASC22 Combined With ART in Subjects With HIV [Phase 2]
Phase 2 trial evaluating ASC22 in combination with antiretroviral therapy for HIV infection has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: Exploration of the Neo-Vagina Study [NA]
Completed update for the Neo-Vagina Study sponsored by the Thai Red Cross AIDS Research Centre, involving transgender women including those …
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: Assessment of Drug-drug Interactions Between Feminizing Hormone Therapy and Emtricitabine/Tenofovir Alafenamide Concomitantly for Pre-exposure Prophylaxis Among Transgender Women [NA]
An ongoing clinical trial update assessing potential drug–drug interactions between feminizing hormone therapy and emtricitabine/tenofovir a…
-
FDA approval · 2024-11-22FDA Approved: EFAVIRENZ — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' supplemental application for efavirenz, a generic antiretroviral for HIV-1 infection.
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: Reducing HIV-related Stigma in School Children in Northern Uganda [NA]
Completed clinical trial evaluating strategies to reduce HIV-related stigma among school children in Northern Uganda. The study also aimed t…
-
FDA approval · 2024-11-21FDA Approved: EMTRICITABINE — Supplemental Application (Cipla USA Inc.)
FDA approved a supplemental application for Emtricitabine submitted by Cipla USA Inc., updating the approved labeling for the drug.
-
FDA approval · 2024-11-21FDA Approved: EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's supplemental application for a generic fixed-dose combination of efavirenz, emtricitabine and tenofovir disoproxil f…
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: Testing a Real-time Electronic Antiretroviral Adherence Monitoring Intervention [Phase 3]
A Phase 3 clinical trial update for a real-time electronic adherence monitoring intervention to support antiretroviral therapy in HIV infect…
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: Mechanisms of Cardiac Dysfunction in HIV and the Effect of Statins: a Cardiac MRI Study
The study investigates mechanisms of cardiac dysfunction in people with HIV and evaluates the impact of statins on cardiac MRI outcomes.
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Protease Inhibitor Vs. Raltegravir-based ART and Inflammation in HIV Infection [Phase 4]
Phase 4 trial comparing protease inhibitor–based ART with raltegravir-based ART in HIV infection has completed; the snippet does not include…
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Camu Camu in ART-treated People Living with HIV [Phase 1]
This update reports the completion of a Phase 1 trial evaluating Camu Camu in ART-treated people living with HIV. The study is sponsored by …
-
CLINICAL_TRIALS research · 2024-11-19Clinical Trial Update: An Acceptance Based PrEP Intervention to Engage Young Black MSM in the South [NA]
A clinical trial investigating an acceptance-based PrEP intervention to engage young Black men who have sex with men in the Southern United …
-
CLINICAL_TRIALS research · 2024-11-19Clinical Trial Update: Caspofungin for Pneumocystis Pneumonia in PLWHIV.
A clinical trial is evaluating caspofungin (Cancidas) for Pneumocystis pneumonia in people living with HIV, and recruitment is ongoing.
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: Increasing Neonatal HIV Test and Treat to Maximize the Long-Term Impact on Infant Health and Novel Infant Antiretroviral Treatment
This clinical trial update describes a study aimed at increasing neonatal HIV testing and initiating antiretroviral treatment in newborns to…
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: Evaluation of 3T, a Sex-Positive HIV/STI Mobile App Intervention for Young Black Men Ages 14-19 Attracted to Men [NA]
A completed clinical trial evaluated the 3T mobile app intervention designed to reduce HIV/STI risk among young Black men who have sex with …
-
CLINICAL_TRIALS research · 2024-11-15Clinical Trial Update: T-cell Responses to Concurrent HIV and Herpesvirus Infections
A completed clinical trial update examining T-cell responses during concurrent HIV and herpesvirus infections.
-
FDA approval · 2024-11-14FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for the generic combination emtricitabine and tenofovir disoproxil fumarate from Strides Pharma Scie…